Vertex Pharmaceuticals Posts Higher 1Q Profit, Sales
April 29 2021 - 4:42PM
Dow Jones News
By Kimberly Chin
Vertex Pharmaceuticals Inc. reported higher profit for the first
quarter, driven by strong revenue growth across its products.
The biopharmaceutical company said net profit was $653.1
million, up from $602.8 million a year earlier. On a per-share
basis, profit rose to $2.49 from $2.29 a year ago. Adjusted
earnings were $2.98 a share. Analysts polled by FactSet expected
$2.44 a share, or $2.70 a share on an adjusted basis.
Total revenue rose to $1.72 billion from $1.52 billion a year
earlier. Analysts were looking for $1.66 billion. Vertex saw an
increase in sales from Kaftrio in Europe and Trikafta in the
U.S.
Write to Kimberly Chin at kimberly.chin@wsj.com
(END) Dow Jones Newswires
April 29, 2021 16:27 ET (20:27 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024
